APA (7th ed.) Citation

Ogdie, A., Middaugh, N., Blachley, T., Bourgeois, T., Ling, Y., Mundayat, R., . . . Mease, P. J. (2026). Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. Rheumatology & Therapy, 13(1), 195. https://doi.org/10.1007/s40744-025-00811-4

Chicago Style (17th ed.) Citation

Ogdie, Alexis, Nicole Middaugh, Taylor Blachley, Tran Bourgeois, You-Li Ling, Rajiv Mundayat, Lara Fallon, Karim R. Masri, and Philip J. Mease. "Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry." Rheumatology & Therapy 13, no. 1 (2026): 195. https://doi.org/10.1007/s40744-025-00811-4.

MLA (9th ed.) Citation

Ogdie, Alexis, et al. "Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry." Rheumatology & Therapy, vol. 13, no. 1, 2026, p. 195, https://doi.org/10.1007/s40744-025-00811-4.